Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series
Abstract Most of the post‐renal transplant patients are taking immunosuppressive medications, including calcineurin inhibitors, anti‐proliferative agents, and steroids. This case series highlights the clinical characteristics and outcomes of eight post‐renal transplant patients with severe COVID‐19...
Main Authors: | Nissar Shaikh, Mohamad Y. Khatib, Mohammad A. Alwraidat, Dore C. Ananthegowda, Muftah Othman, Asra Aroos, Sagar B. Jujjavarapu, Saptarshi Banerjee, Zishan Nasir, Ahmed S. Mohamed, Moustafa S. Elshafei, Muna A. Almaslamani, Abdulqadir J. Nashwan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-07-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.4513 |
Similar Items
-
Induction immunosuppression in kidney transplantation: Thymoglobulin® (a literature review)
by: A. V. Pinchuk
Published: (2016-02-01) -
Tacrolimus-Based Immunosuppressive Therapy Influences Sex Hormone Profile in Renal-Transplant Recipients—A Research Study
by: Dagmara Szypulska-Koziarska, et al.
Published: (2021-07-01) -
Intracytoplasmic sperm injection in male renal transplant recipients
by: Murat Berkkanoglu, et al.
Published: (2015-06-01) -
Pulmão e transplante renal Lung and renal transplantation
by: Patrícia Caetano Mota, et al.
Published: (2009-11-01) -
Torquetenovirus Serum Load and Long-Term Outcomes in Renal Transplant Recipients
by: Edmund J. Gore, et al.
Published: (2020-02-01)